Aptitude Health

09/03/2026

Reserve your EPICS Conference Coverage Report for ESMO 2026 or click the link to learn more: https://www.aptitudehealth.com/oncology-reports/?utm_source=Social&utm_medium=Post

This November, Aptitude Health will release an EPICS Conference Coverage Report for ESMO 2026, offering expert perspectives on the latest data in gynecologic cancers.​

Developed through focused roundtable discussions with leading oncology specialists, the report highlights the clinical relevance and strategic impact of newly presented findings.

09/02/2026

Every 3 minutes, someone in the United Sates is diagnosed with leukemia, lymphoma, or myeloma.¹ Globally, lymphoma and leukemia remain the most common hematologic malignancies,² highlighting the continued need for progress across blood cancer care.​

This World Leukemia and Lymphoma Awareness Month, we stand with patients, caregivers, health care professionals, and advocates dedicated to advancing blood cancer awareness and care.​

By raising awareness and supporting ongoing research and education, we can help drive progress for those affected by blood cancers.​

¹ https://bloodcancerunited.org/blood-cancer/blood-cancer-facts-and-statistics​
² https://pmc.ncbi.nlm.nih.gov/articles/PMC12328193/​

Awareness

09/01/2026

Chemoimmunotherapy vs PD-(L)1 monotherapy in PD-L1–high : Meta-analysis of 24 phase III trials shows median OS of 29.2 vs 19.8 months, supporting combination therapy as first-line consideration. Read more:

A reconstructed individual patient data meta-analysis of 24 phase III RCTs found that chemoimmunotherapy was associated with significantly improved OS and PFS compared with PD-(L)1 inhibitor monotherapy in patients with advanced NSCLC and high PD-L1 expression.

08/27/2026

Aptitude Health will deliver the EPICS Insights Report for breast cancer, capturing key data presented at through closed-door roundtable discussions with global oncology experts.​

📅 October 28-29, 2026 • Virtual Program​

✅ Silent observation opportunities​
✅ Actionable insights from expert-led analysis​
✅ Comprehensive reports to inform your 2026 strategy​

Get the report: https://www.aptitudehealth.com/oncology-reports/?utm_source=Social&utm_medium=Post

08/26/2026

Advancing cancer care begins with shared expertise. Amanda Allen, Associate Director of Aptitude Health's Axess Network, plays a key role in engaging a global community of physicians and oncology experts whose perspectives inform research, clinical development, and patient care.

By building trusted relationships and fostering meaningful collaboration, Amanda and the Axess Network team strengthen a community where insights drive innovation, inform clinical decisions, and improve outcomes for patients worldwide.​

08/25/2026

Gain a global view of lung cancer with Aptitude Health's EPICS: Global Perspectives in Lung Cancer From ESMO 2026.​

This EPICS Insights Report for lung cancer captures key data presented at through closed-door roundtable discussions with global oncology experts.​

Madrid, Spain | October 26, 2026​

✅ Silent observation opportunities​
✅ Actionable insights from expert-led analyses​
✅ Comprehensive reports to inform your 2026 strategy​

Turn conference data into meaningful insights for your team with expert perspectives.​

Reserve your EPICS Global Perspectives Report today: https://www.aptitudehealth.com/oncology-reports/?utm_source=Social&utm_medium=Post

08/20/2026

Real-world data tells what's happening. OncoJourney helps life science teams understand why.​

OncoJourney combines system-specific real-world data with on-site clinician interpretation in multidisciplinary sessions to surface the true “why” behind patient journey variation and then converts data into aligned action within a health system.​

The result? A deeper understanding of treatment decisions, patient journey variation, and the factors shaping care.​

Learn more: https://www.aptitudehealth.com/real-world-evidence/oncojourney/?utm_source=Social&utm_medium=Post&utm_campaign=OncoJourney

08/19/2026

Aptitude Health is the leading provider of evidence-based insights and HCP engagement in oncology and hematology. Powered by our proprietary Axess Network of 6,500+ experts, we help life science teams move beyond data to understand what’s truly driving health care decisions.​

Learn more: https://www.aptitudehealth.com/?utm_source=Post&utm_medium=Facebook

08/18/2026

Connect with us at SOHO and explore how our insights can elevate your hematology strategy: https://www.aptitudehealth.com/contact-us/.​

As the leading provider of evidence-based insights and HCP engagement in oncology and hematology, we help life science companies make informed decisions with confidence.

08/13/2026

Are you overlooking critical regional nuances in community oncology? Our latest white paper uncovers how local dynamics influence treatment decision-making—and what it means for your commercial strategy.​

Get the insights to move beyond a one-size-fits-all approach.​

Download now: https://www.aptitudehealth.com/oncology-news/white-paper-regional-variations-in-community-oncology-practices/?utm_source=Social&utm_medium=Post&utm_campaign=whitepaper